Vaxess Technologies is an innovative life sciences company based in the brand new Harvard Life Lab in Boston Massachusetts. Formed in 2012 by founders from Harvard and Tufts Universities, our company is developing proprietary technologies based on a silk biopolymer platform for encapsulating and stabilizing biological compounds.
We work with our partners to develop therapeutic and diagnostic products that are highly innovative in presentation format and robust under extreme environmental conditions, such as exposure to high temperatures outside of cold chain storage and transportation.
Harvard President’s Challenge First Prize Winner
Harvard Business School New Venture Competition First Prize Winner
2012 - 2013
Mass Technology Leadership Council Awards:
Innovative Technology of the Year
Vaccine Industry Excellence Awards:
Highly Recommended for Best Technological Development and Best Financing Deal
Verizon Powerful Answers Awards First Prize Winner